H. pylori Eradication complementary strategy for Vitiligo Management, suggests study

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2026-02-26 14:45 GMT | Update On 2026-02-27 06:37 GMT

The findings of a new study suggest a possible association between H. pylori infection and the pathophysiology of vitiligo. Based on this link, H. pylori eradication therapy may serve as a complementary strategy alongside standard vitiligo treatments and could have additional relevance in patients with Multiple Autoimmune Syndrome.

Multiple Autoimmune Syndrome (MAS) involves at least three distinct autoimmune diseases. MAS’ exact cause is unknown, however, genetic, immunologic, environmental, and infectious factors like Helicobacter pylori (H.pylori) are involved in its pathophysiology.

Hence, in the current study, we described the demographic, and clinical characteristics of Multiple Sclerosis (MS) patients coexisting with vitiligo. Furthermore, we investigated the relationship between H. pylori eradication and patients’ clinical improvement. In this case-series study, eight female MS patients with clinically confirmed vitiligo were assessed for demographic and clinical characteristics via questionnaires and medical records. H. pylori infection also was evaluated using ELISA and stool antigen (HpSag) tests, and positive cases received eradication therapy.

Results: The mean onset ages for MS and vitiligo were 23.12 ± 5.27 and 26.75 ± 4.97 years, with disease durations of 10.4 and 6.8 years, respectively. Six patients (75%) had an active vitiligo, and only one had active MS. Family history of MS and vitiligo was observed in 37.5% and 50% of patients, while 87.5% had other autoimmune diseases in their families. The mean H.pylori IgG and IgM levels were 15.58 ± 13.63 and 0.43 ± 0.31, respectively and H. pylori infection was detected in 25% of patients by either serology or stool antigen test, and no active vitiligo was observed post-eradication.

Since, the findings showed a potential association between H. pylori infection and the pathophysiology of vitiligo, eradication therapy may be used as a complementary approach alongside standard vitiligo treatments or even MS in Multiple Autoimmune Syndrome patients.

Reference:

Maryam Aghaei, Shahrzad Aghaei, Zabihollah Shahmoradi, Asieh Heidari, Fereshteh Ashtari, Seyed Hossein Hejazi. Evaluation of Helicobacter pylori infection and clinical features in multiple sclerosis patients coexisting with vitiligo: Case-series, Journal of the National Medical Association, 2026, ISSN 0027-9684, https://doi.org/10.1016/j.jnma.2026.01.007. (https://www.sciencedirect.com/science/article/pii/S0027968426000167)

Article Source : Journal of the National Medical Association

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Dr. Shravani Dali

Dr. Shravani Dali has completed her BDS from Pravara institute of medical sciences, loni. Following which she extensively worked in the healthcare sector for 2+ years. She has been actively involved in writing blogs in field of health and wellness. Currently she is pursuing her Masters of public health-health administration from Tata institute of social sciences. She can be contacted at editorial@medicaldialogues.in.

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

H. pylori Eradication complementary strategy for Vitiligo Management, suggests study

Similar News

Linezolid Comparable to Clindamycin in Severe or Necrotizing SSTIs, Suggests Study

Icotrokinra Shows Strong Efficacy and Safety in Plaque Psoriasis: Meta-Analysis

Hidradenitis Suppurativa Linked to Higher Risk of Self-Harm and Suicide: JAMA

Semaglutide Improves Clinical and Metabolic Outcomes in Hidradenitis Suppurativa with Obesity: Study

FDA Approves Deucravacitinib for Active Psoriatic Arthritis

Nemolizumab Demonstrates Sustained Long-Term Benefit in Prurigo Nodularis: Study

Dupilumab restores skin barrier function in children with moderate-to-severe atopic dermatitis, study shows

Once-Daily Roflumilast Cream Delivers Lasting Benefits in Atopic Dermatitis: Study Shows